Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL

1 Views
administrator
administrator
08/09/23

Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next